Andreas Borg (@_andreasborg) header
Andreas Borg (@_andreasborg) profile picture

Founder CURE5 #CDKL5 #TraversalBio

New York / Lisbon
Joined July 2009
Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)Photo by Andreas Borg (@_andreasborg)
Excited to share that CURE5 is partnering with BrainStorm Therapeutics on an ambitious new initiative: EveryStone. As featured in NVIDIA’s latest blog, EveryStone will conduct the most comprehensive repurposed drug screen to date for CDKL5 Deficiency Disorder. #CDKL5
1
2
445
I feel tremendous energy and change will come from the #geneticagency movement, and I'm here for it. Getting everyone working together will clear the roadblocks for genetic medicine. Thank you @Dyno_Tx for leading the way.
One of the most important purposes of gathering at a conference is interaction. Especially at GATC, where we're bringing together professionals on all sides of #geneticagency: from physicians, to technologists, to patients and their families. That's why we've facilitated even more small platform sessions this year, featuring speakers from Harvard Medical School, Brain Repair Foundation, @arcinstitute, @openai, and many more organizations working together to advance our common goal.
27
The future of genetic agency is upon us. We're gathered at GATC to not only define it, but to bring it to fruition. And we'll get there by working together effectively. Dyno cofounder and CEO @ekelsic kicks off GATC 2026 with exactly that message. #geneticagency
1
3
6
396
I’m excited to be giving my talk “Building the Future I Wish Existed” at the Genetic Agency Technology Conference (#GATC26) on Nov 18, presented by @Dyno_Tx – joining a community that’s building the future of #GeneticAgency. Learn more & apply today → dynotx.com/gatc2026
1
36
Andreas Borg retweeted
Today, we are excited to introduce Ladon, a state-of-the-art biological foundation model that predicts disease trajectory and treatment response in patients. There is immense complexity in the individual biology of every patient. Two patients can have the same diagnosis and receive the same treatment, yet have very different outcomes: one responds well and lives for years, while the other’s disease continues to progress. Understanding and resolving this heterogeneity to predict outcomes is how we accelerate our delivery of medicines for patients and unlock clinical trial abundance. Ladon is our first step towards this future: one where we can learn more from every patient enrolled so that we can run smaller, faster trials with higher success rates. We built it to give drug developers quantitative support on billion-dollar clinical trial decisions. Today we're excited to share Ladon's capabilities in our blog and technical report. Ladon is a 3B parameter model trained on millions of RNA-seq samples spanning decades of technical and biological variation across tissues and species. Ladon beats gene expression baselines, established biomarkers, and existing RNA foundation models at predicting patient prognosis and therapeutic response in 140+ oncology tasks, including external validation on past clinical trials. This is significant because clinical trials are fundamentally generalization problems. We show that Ladon-derived predictions are robust across indications, treatments, and sequencing platforms. Reach out if you’d like to get started with the model today! Read more about Ladon in the blog: blank.bio/introducing-ladon Find more technical details in the white paper: blank.bio/introducing-ladon
45
125
23
609
49,746
Andreas Borg retweeted
Narrator: they did not get to work.
152
6,114
59
75,684
682,826
NYC is like an LLM, it has all the answers but it won't give then up to you unless you ask the right questions. The same street corner can mean a thousand different things depending on where you're at in life. Both could be easier.
1
55
"a network’s parts are built to be read, and built upon, by its downstream readers.//a neural network is almost a fractal of explanations, of coherent, useful groupings: at the macro scale, in its mechanisms, and at the micro scale, where recursive generalization shapes each one"
interpretability might be the most important scientific problem in the world right now, as I don't think we can solve alignment if we don't know what we're building. I think I have good news about it. I co-authored early work in mechanistic interpretability at OpenAI and came away pessimistic, because neural networks appeared to fold into arbitrary tangled knots. years later, I started openai's first large-scale automated interpretability project, finding about 2% of neurons legible with the primitive tools we had with modern agentic tools and a much closer look, the picture looks totally different. the vast majority in models up to trillions of parameters are legible, and their circuits beautiful. many famous examples of tangled neurons turned out to be misunderstood. The roadblocks I expected mostly aren't there. I now think ambitious interpretability will be solved by the time we need it most, and possibly quite soon, as automated scientists keep improving. it may be a bitter lesson for interpretability: the simple thing, at absurd scale, works already-clean.goodfire.com/
46
We are bringing agents to the wet-lab bench at Google Research to navigate complex biological landscapes. Learn how we are grounding agents in physical lab robotics to run fast closed-loop molecular design cycles, ultimately discovering single-digit nanomolar protein binders for cancer targets →goo.gle/4B5mMMB
110
480
118
3,700
315,266
We are giving away 1 MILLION LigandForge designs as part of the Adaptyv Proteinbase + Anthropic protein design competition. challenge.ligandai.com
4
13
67
185,729
github.com/storytold Someone(s) recreated all Adobe apps in Rust using Opus5.5. I tested Photoshop quickly and couldn't tell the difference. It was ported to open source in a week! Decades of a closely guarded code empire falling. Wild.
59
Unless ownership changes radically there’s nothing stopping wealth rushing to the top. For AI to benefit all, worker-owned companies need to be the default, and to be a citizen mean to be national equity holder, rightfully sharing dividends.
On Tuesday, Elon Musk stood outside the West Wing next to the President and said the most likely future is an age of abundance. A universal high income. Bigger than basic. For everyone. A reporter called back, "Not if they haven't got a job." And Elon said, "Jobs are going to change. Jobs have always changed." I've been sitting with that exchange for days. You know me. I'm the eternal optimist. I went all in on AI in January 2023, the same season I watched it replace the writing I'd built my whole life on. I burned my ships. I'd burn them again. So I'm going to be honest with you. I truly don't know if this is good for us. I really don't. I see the good. I see it so clearly it almost hurts. A doctor in the pocket of a kid in a village who's never seen one. A single mom getting her evenings back with her children. My own clone makes more content than I ever did with my own two hands. I live that freedom every single day. I should be the last person afraid of this. And some nights, I still am. Because I also see what's happening to us in the quiet. I see people handing over the thinking, and then forgetting how. Skills we spent decades building going soft, like a muscle nobody asks to lift anymore. Ask the machine. Copy. Paste. Scroll. Somewhere in there, a little bit of us stops showing up. And I think about the students. The 19-year-old in a lecture hall right now, paying for a degree built for a world that might be gone by the time she walks across that stage. Who tells her what to study? Who tells her what she'll be needed for? I don't know. I'm not sure anyone in that room at the White House knows either. A high income is a beautiful promise. I didn't hear one word about who pays for it. And even if the checks come, work gave us more than a paycheck. It gave us somewhere to be good at something, and people counting on us to show up. I've spent this whole year telling people you were never your output. I still believe that with everything in me. But a mind that stops reaching gets smaller. I've watched it happen. So I'll keep building. Eyes open. Heart open. And I'll keep asking the hard questions out loud, because the most powerful people in the world sounded awfully sure on Tuesday. I'm not sure. I think some of us need to say that. Our minds are still ours to keep sharp. I want us to keep them. Where do you land on this? I'm reading every reply.
1
35
An experiment I did 10 years ago seems archaic today “Machines watching movies” vimeo.com/163099063?ref=tw-s…
The whole point of building Tavus has been simple: talking to a machine should feel as natural as talking to a friend or coworker. It’s hard to describe all the tiny nuances that make a conversation feel human. The little expressions. Moving around in your chair. Knowing when to speak and when to listen. The dance of it all. Griffin is by far the closest anyone has come to a model that can capture those nuances. The first time I saw it being used, I had no idea I was watching our model rather than just a normal video call. I’m so incredibly proud of this team and what they’ve built.
1
1
85
Where are the data privacy protected options?
Just the Editor-in-Chief of Nature advising scientists not to share their data and findings with external AI model companies.
58
So where does that leave us regarding LLMs ability to discover significant novel ideas? Are there any irrefutable cases?
Anthropic's discovery of array-associated reverse transcriptases? Turns out it was already done by a Danish scientist. He used Claude for administrative tasks, but not in an agentic manner for the discovery. He already filed a patent and gave talks on it nytimes.com/2026/09/27/scien…
69
I recently had the opportunity to speak at EURORDIS-Rare Diseases Europe about AI and drug repurposing. I went to talk about how AI can accelerate rare disease research. I came away thinking that rare disease may be showing us the future of medicine. substack.com/home/post/p-216…
5
65
As it is increasingly economically feasible to make treatment decisions at the level of the individual rather than the population average, patients will increasingly expect that level of care. What begins as necessity in rare disease may become the standard of care for everyone.
15
Currently the intellectual labor needed makes that economically unrealistic, but if increasingly capable AI systems can do much of the cognitive work for a fraction of that cost, the boundary moves.
11
In an ideal world everything would be tailor-made for you. Your doctor would know everything about you, your unique genetic and metabolic makeup, your epigenetics, historical diet, stress levels and environmental exposures.
11
What we have today is an average-based medicine, not because everyone is treated the same, but because enough patients cluster around local averages to justify the investment.
11